US equities
|
META
$630.56
▲+0.00%
MU
$903.70
▲+0.00%
TSLA
$391.62
▲+0.00%
NVDA
$216.00
▲+0.00%
SPCX
$146.90
▲+0.00%
SNDK
$1,255.58
▲+0.00%
INTC
$90.47
▲+0.00%
AMD
$531.28
▲+0.00%
META
$630.56
▲+0.00%
MU
$903.70
▲+0.00%
TSLA
$391.62
▲+0.00%
NVDA
$216.00
▲+0.00%
SPCX
$146.90
▲+0.00%
SNDK
$1,255.58
▲+0.00%
INTC
$90.47
▲+0.00%
AMD
$531.28
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Apollo Endosurgery, Inc. - Common Stock
(NQ:
APEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Apollo Endosurgery, Inc. - Common Stock
< Previous
1
2
3
Next >
Apollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022
August 02, 2022
Via
ACCESSWIRE
Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure
July 29, 2022
Via
ACCESSWIRE
Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure
July 29, 2022
Publication of MERIT Study Follows FDA Market Authorization of Apollo ESG™
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery to Report Second Quarter Results on August 2, 2022
July 21, 2022
Via
ACCESSWIRE
Apollo Endosurgery to Report Second Quarter Results on August 2, 2022
July 21, 2022
AUSTIN, TX / ACCESSWIRE / July 21, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery's New Obesity Endoscopic Systems Receive FDA Nod
↗
July 13, 2022
Via
Benzinga
This Analyst Thinks Apollo Endosurgery's Valuation 'Does Not Assign Full Value' - Read Why
↗
May 04, 2022
Via
Benzinga
Apollo Endosurgery: Q1 Earnings Insights
↗
May 03, 2022
Apollo Endosurgery (NASDAQ:APEN) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday
↗
July 14, 2022
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.
Via
Benzinga
Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session
↗
July 13, 2022
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.
Via
Benzinga
Earnings Scheduled For February 22, 2022
↗
February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
July 13, 2022
Via
Benzinga
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity
July 13, 2022
Systems Offer Effective, Minimally Invasive Treatment Options for Millions of Patients with Obesity (BMI 30-50 kg/m2)
From
Apollo Endosurgery, Inc.
Via
AccessWire
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG and Apollo REVISE, New Endoscopic Systems for Patients with Obesity
July 13, 2022
Via
ACN Newswire
Sharon O'Keefe Joins Apollo Endosurgery Board of Directors
July 06, 2022
Seasoned healthcare leader brings 30 years of hospital system and medical technology expertise
From
Apollo Endosurgery, Inc.
Via
AccessWire
Digestive Disease Week 2022 Adds to the Growing Wave of Clinical Evidence Supporting Significant Opportunity for Apollo Endosurgery Products
May 31, 2022
AUSTIN, TX / ACCESSWIRE / May 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery Products to Take Center Stage at Digestive Disease Week
May 18, 2022
AUSTIN, TX / ACCESSWIRE / May 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery, Inc. Reports 33% U.S. Revenue Growth in First Quarter 2022
May 03, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery to Report First Quarter Results on May 3, 2022
April 13, 2022
AUSTIN, TX / ACCESSWIRE / April 13, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (Nasdaq:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors
April 04, 2022
Veteran Brings 30 Years of Multinational Healthcare Leadership Experience AUSTIN, TX / ACCESSWIRE / April 4, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally...
From
Apollo Endosurgery, Inc.
Via
AccessWire
68 Biggest Movers From Yesterday
↗
March 03, 2022
Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to...
Via
Benzinga
Apollo Endosurgery to Participate in the Cowen Healthcare Conference
March 02, 2022
AUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery's Return On Capital Employed Insights
↗
February 23, 2022
Apollo Endosurgery (NASDAQ:APEN) brought in sales totaling $16.17 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 56.3%, resulting in a...
Via
Benzinga
Recap: Apollo Endosurgery Q4 Earnings
↗
February 22, 2022
Apollo Endosurgery (NASDAQ:APEN) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:01 PM. Here's what investors need to know about the announcement....
Via
Benzinga
Apollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021
February 22, 2022
- Increased adoption across all product lines in both U.S. and international - Grew fourth quarter 2021 revenue 26% AUSTIN, TX / ACCESSWIRE / February 22, 2022 / Apollo Endosurgery, Inc. ("Apollo")...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery to Report Fourth Quarter and Full Year Results on February 22, 2022
February 10, 2022
AUSTIN, TX / ACCESSWIRE / February 10, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access
January 18, 2022
Veteran Leader Brings 25 Years of Global Medical Device Experience AUSTIN, TX / ACCESSWIRE / January 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020
January 10, 2022
Fourth quarter 2021 revenue grew 25% over 2020 AUSTIN, TX / ACCESSWIRE / January 10, 2022 / Apollo Endosurgery, Inc. ("Apollo" or the "Company") (NASDAQ:APEN), a global leader in less invasive medical...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLC
December 21, 2021
- $35 million funded at close to refinance existing debt, extend maturity and lower interest expense - Additional borrowing capacity provides minimally dilutive growth capital and strategic flexibility...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
↗
December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE:
Via
Benzinga
< Previous
1
2
3
Next >
